These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24384301)
1. Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL. Gugliucci A; Kinugasa E; Ogata H; Caccavello R; Kimura S Clin Chim Acta; 2014 Mar; 430():9-14. PubMed ID: 24384301 [TBL] [Abstract][Full Text] [Related]
2. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. Gugliucci A Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342 [TBL] [Abstract][Full Text] [Related]
6. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294 [TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis. Gugliucci A; Kinugasa E; Kotani K; Caccavello R; Kimura S Clin Chem Lab Med; 2011 Jan; 49(1):61-7. PubMed ID: 20961187 [TBL] [Abstract][Full Text] [Related]
8. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes. Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650 [TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood. Gugliucci A; Numaguchi M; Caccavello R; Kimura S Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935 [TBL] [Abstract][Full Text] [Related]
11. Main determinants of PON1 activity in hemodialysis patients. Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074 [TBL] [Abstract][Full Text] [Related]
12. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Deakin S; Moren X; James RW Atherosclerosis; 2005 Mar; 179(1):17-25. PubMed ID: 15721005 [TBL] [Abstract][Full Text] [Related]
13. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Gaidukov L; Tawfik DS Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586 [TBL] [Abstract][Full Text] [Related]
14. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes. Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214 [TBL] [Abstract][Full Text] [Related]
15. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720 [TBL] [Abstract][Full Text] [Related]
16. Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1-Q192R phenotype. Turgay F; Şişman AR; Aksu AÇ J Atheroscler Thromb; 2015; 22(3):313-26. PubMed ID: 25735253 [TBL] [Abstract][Full Text] [Related]
17. The paraoxonase 1, 2 and 3 in humans. Rajkovic MG; Rumora L; Barisic K Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851 [TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis. Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020 [TBL] [Abstract][Full Text] [Related]
19. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Sutherland WH; de Jong SA; Walker RJ Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042 [TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Rosenblat M; Karry R; Aviram M Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]